Operating Income (Loss) of Medtronic plc from 26 Apr 2013 to 23 Jan 2026

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Medtronic plc quarterly and annual Operating Income (Loss) in USD history and change rate from 26 Apr 2013 to 23 Jan 2026.
  • Medtronic plc Operating Income (Loss) for the quarter ending 23 Jan 2026 was $1,464,000,000, a 11% decline year-over-year.
  • Medtronic plc Operating Income (Loss) for the twelve months ending 23 Jan 2026 was $6,031,000,000, a 8.2% increase year-over-year.
  • Medtronic plc annual Operating Income (Loss) for 2024 was $5,955,000,000, a 16% increase from 2023.
  • Medtronic plc annual Operating Income (Loss) for 2023 was $5,144,000,000, a 6.2% decline from 2022.
  • Medtronic plc annual Operating Income (Loss) for 2022 was $5,485,000,000, a 4.6% decline from 2021.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Medtronic plc Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $6,031,000,000 $1,464,000,000 -$182,000,000 -11% 25 Oct 2025 23 Jan 2026 10-Q 24 Feb 2026 2026 Q3
Q3 2025 $6,213,000,000 $1,686,000,000 +$91,000,000 +5.7% 26 Jul 2025 24 Oct 2025 10-Q 25 Nov 2025 2026 Q2
Q2 2025 $6,122,000,000 $1,445,000,000 +$167,000,000 +13% 26 Apr 2025 25 Jul 2025 10-Q 26 Aug 2025 2026 Q1
Q1 2025 $5,955,000,000 $1,436,000,000 +$383,000,000 +36% 25 Jan 2025 25 Apr 2025 10-K 20 Jun 2025 2025 FY
Q4 2024 $5,572,000,000 $1,646,000,000 +$163,000,000 +11% 26 Oct 2024 24 Jan 2025 10-Q 24 Feb 2026 2026 Q3
Q3 2024 $5,409,000,000 $1,595,000,000 +$255,000,000 +19% 27 Jul 2024 25 Oct 2024 10-Q 25 Nov 2025 2026 Q2
Q2 2024 $5,154,000,000 $1,278,000,000 +$10,000,000 +0.79% 27 Apr 2024 26 Jul 2024 10-Q 26 Aug 2025 2026 Q1
Q1 2024 $5,144,000,000 $1,053,000,000 -$511,000,000 -33% 27 Jan 2024 26 Apr 2024 10-K 20 Jun 2025 2025 FY
Q4 2023 $5,655,000,000 $1,483,000,000 +$91,000,000 +6.5% 28 Oct 2023 26 Jan 2024 10-Q 25 Feb 2025 2025 Q3
Q3 2023 $5,564,000,000 $1,340,000,000 -$64,000,000 -4.6% 29 Jul 2023 27 Oct 2023 10-Q 26 Nov 2024 2025 Q2
Q2 2023 $5,628,000,000 $1,268,000,000 +$143,000,000 +13% 29 Apr 2023 28 Jul 2023 10-Q 27 Aug 2024 2025 Q1
Q1 2023 $5,485,000,000 $1,564,000,000 -$107,000,000 -6.4% 28 Jan 2023 28 Apr 2023 10-K 20 Jun 2025 2025 FY
Q4 2022 $5,592,000,000 $1,392,000,000 -$267,000,000 -16% 29 Oct 2022 27 Jan 2023 10-Q 27 Feb 2024 2024 Q3
Q3 2022 $5,859,000,000 $1,404,000,000 -$159,000,000 -10% 30 Jul 2022 28 Oct 2022 10-Q 30 Nov 2023 2024 Q2
Q2 2022 $6,018,000,000 $1,125,000,000 +$266,000,000 +31% 30 Apr 2022 29 Jul 2022 10-Q 31 Aug 2023 2024 Q1
Q1 2022 $5,752,000,000 $1,671,000,000 +$67,000,000 +4.2% 29 Jan 2022 29 Apr 2022 10-K 20 Jun 2024 2024 FY
Q4 2021 $5,685,000,000 $1,659,000,000 +$382,000,000 +30% 30 Oct 2021 28 Jan 2022 10-Q 01 Mar 2023 2023 Q3
Q3 2021 $5,303,000,000 $1,563,000,000 +$633,000,000 +68% 31 Jul 2021 29 Oct 2021 10-Q 01 Dec 2022 2023 Q2
Q2 2021 $4,670,000,000 $859,000,000 +$186,000,000 +28% 01 May 2021 30 Jul 2021 10-Q 01 Sep 2022 2023 Q1
Q1 2021 $4,484,000,000 $1,604,000,000 +$1,288,000,000 +408% 30 Jan 2021 30 Apr 2021 10-K 22 Jun 2023 2023 FY
Q4 2020 $3,196,000,000 $1,277,000,000 -$362,000,000 -22% 31 Oct 2020 29 Jan 2021 10-Q 03 Mar 2022 2022 Q3
Q3 2020 $3,558,000,000 $930,000,000 -$421,000,000 -31% 01 Aug 2020 30 Oct 2020 10-Q 02 Dec 2021 2022 Q2
Q2 2020 $3,979,000,000 $673,000,000 -$812,000,000 -55% 25 Apr 2020 31 Jul 2020 10-Q 02 Sep 2021 2022 Q1
Q1 2020 $4,791,000,000 $316,000,000 -$1,630,000,000 -84% 25 Jan 2020 24 Apr 2020 10-K 23 Jun 2022 2022 FY
Q4 2019 $6,421,000,000 $1,639,000,000 +$97,000,000 +6.3% 26 Oct 2019 24 Jan 2020 10-Q 05 Mar 2021 2021 Q3
Q3 2019 $6,324,000,000 $1,351,000,000 -$193,000,000 -12% 27 Jul 2019 25 Oct 2019 10-Q 03 Dec 2020 2021 Q2
Q2 2019 $6,517,000,000 $1,485,000,000 +$249,000,000 +20% 27 Apr 2019 26 Jul 2019 10-Q 03 Sep 2020 2021 Q1
Q1 2019 $6,268,000,000 $1,946,000,000 +$18,000,000 +0.93% 26 Jan 2019 26 Apr 2019 10-K 25 Jun 2021 2021 FY
Q4 2018 $6,250,000,000 $1,542,000,000 +$106,000,000 +7.4% 27 Oct 2018 25 Jan 2019 10-Q 28 Feb 2020 2020 Q3
Q3 2018 $6,144,000,000 $1,544,000,000 -$350,000,000 -18% 28 Jul 2018 26 Oct 2018 10-Q 03 Dec 2019 2020 Q2
Q2 2018 $6,494,000,000 $1,236,000,000 -$146,000,000 -11% 28 Apr 2018 27 Jul 2018 10-Q 30 Aug 2019 2020 Q1
Q1 2018 $6,640,000,000 $1,928,000,000 +$244,000,000 +14% 27 Jan 2018 27 Apr 2018 10-K 19 Jun 2020 2020 FY
Q4 2017 $6,396,000,000 $1,436,000,000 +$289,000,000 +25% 28 Oct 2017 26 Jan 2018 10-Q 01 Mar 2019 2019 Q3
Q3 2017 $6,107,000,000 $1,894,000,000 +$509,000,000 +37% 29 Jul 2017 27 Oct 2017 10-Q 29 Nov 2018 2019 Q2
Q2 2017 $5,598,000,000 $1,382,000,000 +$215,000,000 +18% 29 Apr 2017 28 Jul 2017 10-Q 31 Aug 2018 2019 Q1
Q1 2017 $5,383,000,000 $1,684,000,000 +$109,000,000 +6.9% 28 Jan 2017 28 Apr 2017 10-K 21 Jun 2019 2019 FY
Q4 2016 $5,274,000,000 $1,147,000,000 -$208,000,000 -15% 29 Oct 2016 27 Jan 2017 10-Q 02 Mar 2018 2018 Q3
Q3 2016 $5,482,000,000 $1,385,000,000 +$85,000,000 +6.5% 30 Jul 2016 28 Oct 2016 10-Q 04 Dec 2017 2018 Q2
Q2 2016 $5,397,000,000 $1,167,000,000 +$36,000,000 +3.2% 30 Apr 2016 29 Jul 2016 10-Q 01 Sep 2017 2018 Q1
Q1 2016 $5,361,000,000 $1,575,000,000 +$1,202,000,000 +322% 30 Jan 2016 29 Apr 2016 10-K 22 Jun 2018 2018 FY
Q4 2015 $4,159,000,000 $1,355,000,000 +$80,000,000 +6.3% 31 Oct 2015 29 Jan 2016 10-Q 03 Mar 2017 2017 Q3
Q3 2015 $4,079,000,000 $1,300,000,000 +$270,000,000 +26% 01 Aug 2015 30 Oct 2015 10-Q 05 Dec 2016 2017 Q2
Q2 2015 $3,809,000,000 $1,131,000,000 +$43,000,000 +4% 25 Apr 2015 31 Jul 2015 10-Q 07 Sep 2016 2017 Q1
Q1 2015 $3,766,000,000 $373,000,000 24 Jan 2015 24 Apr 2015 10-K 27 Jun 2017 2017 FY
Q4 2014 $1,275,000,000 25 Oct 2014 23 Jan 2015 10-Q 09 Mar 2016 2016 Q3
Q3 2014 $1,030,000,000 26 Jul 2014 24 Oct 2014 10-Q 09 Dec 2015 2016 Q2
Q2 2014 $1,088,000,000 26 Apr 2014 25 Jul 2014 10-Q 09 Sep 2015 2016 Q1

Medtronic plc Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $5,955,000,000 +$811,000,000 +16% 27 Apr 2024 25 Apr 2025 10-K 20 Jun 2025 2025 FY
2023 $5,144,000,000 -$341,000,000 -6.2% 29 Apr 2023 26 Apr 2024 10-K 20 Jun 2025 2025 FY
2022 $5,485,000,000 -$267,000,000 -4.6% 30 Apr 2022 28 Apr 2023 10-K 20 Jun 2025 2025 FY
2021 $5,752,000,000 +$1,268,000,000 +28% 01 May 2021 29 Apr 2022 10-K 20 Jun 2024 2024 FY
2020 $4,484,000,000 -$307,000,000 -6.4% 25 Apr 2020 30 Apr 2021 10-K 22 Jun 2023 2023 FY
2019 $4,791,000,000 -$1,477,000,000 -24% 27 Apr 2019 24 Apr 2020 10-K 23 Jun 2022 2022 FY
2018 $6,268,000,000 -$372,000,000 -5.6% 28 Apr 2018 26 Apr 2019 10-K 25 Jun 2021 2021 FY
2017 $6,640,000,000 +$1,257,000,000 +23% 29 Apr 2017 27 Apr 2018 10-K 19 Jun 2020 2020 FY
2016 $5,383,000,000 +$22,000,000 +0.41% 30 Apr 2016 28 Apr 2017 10-K 21 Jun 2019 2019 FY
2015 $5,361,000,000 +$1,595,000,000 +42% 25 Apr 2015 29 Apr 2016 10-K 22 Jun 2018 2018 FY
2014 $3,766,000,000 -$47,000,000 -1.2% 26 Apr 2014 24 Apr 2015 10-K 27 Jun 2017 2017 FY
2013 $3,813,000,000 -$589,000,000 -13% 27 Apr 2013 25 Apr 2014 10-K 28 Jun 2016 2016 FY
2012 $4,402,000,000 28 Apr 2012 26 Apr 2013 10-K 23 Jun 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.